INTRODUCTION
During oxidative stress, a massive production of reactive oxygen species (ROS) induces alterations in cell structure. Oxidative stress may play a role in the onset of a wide variety of disorders [1] and participate at the ageing pro cess [2] . ROS are able to interact with proteins, lipids and DNA leading to the formation of adducts accompanied with a loss of function [3] . These deleterious effects are normally kept under control by antioxidants. Most antioxidant systems are composed of an enzyme (e.g., superoxide dismutase, catalase, glutathione peroxidase [4] ) usually under the control of a nutrient (vitamins or minerals); but besides these "classical" systems, several compounds have been shown to regulate metabolic activity inside the cells preventing the overproduction of ROS. These molecules are not strictly antioxidants but are able to reduce ROS production. Melatonin [5] , creatine [6] , coenzyme Q10 [7] and carnitine [8] belong to this family.
An adult body contains around 25 g of Lcarnitine [9] . LCarnitine found in a human body is either derived from food stuff, especially from meat and dairy products [10] , or derived from an endogenous synthesis. In mammals, Lcarnitine is mainly synthesized in the liver, the testis and the kidney, this biosynthesis requires lysine and methionine as ultimate precursors and five enzymatic reactions [11, 12] . Dietary or biosynthetic carnitine is excreted into the blood stream (at a concentration of 50100 µmol/L) and distributed to organs and tissues depending on Lcarnitine. Among these, muscle concentrates most of the Lcarnitine: In a human body, around 98% of all the Lcarnitine is found in skeletal and heart muscles and the ratio between plasma and muscle carnitine concentration is around 1:50 [13] . None of these organs is able to synthesize Lcarnitine and this molecule has to be imported from the blood stream using specific transporters [14] . The primary role of carnitine is to permit the transport of long chain fatty acids into mitochondria where they can enter the βoxidation pathway. Lcarnitine is also a cofactor for peroxisomal enzymes [15] and recognized as an inhibitor for HDAC [16] . Lcarnitine has also been used as a protective agent against neurotoxic agents. The precise mechanisms involved are still to be clearly identified and several hypotheses remain. Lcarnitine may exert its protective effects as a regulatory element in energy production and/or by interacting with the production of free radicals [17] . ROS production is associated with several muscle diseases [18] and it is clear that improving free radical metabolism could be beneficial to cells, animals or patients with muscle disorders [19] . The goal of this study was to evaluate the beneficial effect that Lcarnitine treatment may exert on muscle cells undergoing an oxidative stress.
MATERIALS AND METHODS

Chemicals
Culture media were purchased from Lonza (Levallois Perret, France). LCarnitine (carnipure™) was a generous gift from Lonza. Probes used for cytometry analyses were purchased from Molecular probes (CergyPontoise, France). All others chemicals were obtained from Sigma Aldrich (St Quentin Fallavier, France).
Cell culture
Murine myoblastic C2C12 cells were obtained from the European Collection of Cell Cultures (ECACC, Salisbury United Kingdom) and cultured according to their recom mendations. Cells were grown in DMEM (Gibco, Cergy Pontoise, France) with 10% heatinactivated fetal calf serum (FCS; Gibco), 4 mmol/L Lglutamine (Gibco) at 37 ℃ in a humidified atmosphere with 5% CO2. Cells were trypsinized when they reached semi confluence. Dishes were seeded at a density of 2000 cells per square centimetre.
Treatments
Menadione was dissolved in 70% ethanol and added to culture medium (without phenol red) at the desired concentration (from 0 to 12 µmol/L); these varying concentrations were used as they may induce from moderate to severe oxidative stress [20] . Cells were treated for 1 to 24 h for all measured parameters. Lcarnitine treated cells were cultured with Lcarnitine at the final concentration of 500 µmol/L, at all the stages of the experiment. Lcarnitine was dissolved in DPBS, filtrated on a 22 µm filter and added to the culture medium. This concentration was chosen as it remains in the physiological range (the extracellular concentration in carnitine is esti mated to be in the 50100 µmol/L range and in the muscle cells this concentration is at least 20 times higher) and as preliminary data showed that this concentration was efficient for limiting oxidative stress. 
Flow cytometric analyses
Propidium Iodide assay
After treatment with menadione and/or Lcarnitine, the culture medium was removed and stored in a 15 mL tube; cells were rinsed with DPBS and trypsinized. The culture medium, the DPBS used for washing and the trypsinized cells were collected and centrifuged at 600 g for 3 min. The supernatant was discarded and the cells resuspended in DPBS. Propidium iodide was added to the cell suspension at a final concentration of 5 µg/mL. After a 5 min incubation, cells were analyzed with a flow cytometer [21] . FL3 fluorescence was recorded for 10000 cells. Lethal dose 50 was determined with the BioStat 2009 software (AnalystSoft) as described in [22] .
Identification of LC3-Ⅱ
LC3 has been used as a marker for autophagy. Cells treated with either Lcarnitine, menadione (as before) and 3methyadenine (final concentration of 5 mmol/L) were harvested, washed twice in icecold PBS and resuspended in a RIPA solution (TrisHCl, 20 mmol/L pH 8.0; 150 mmol/L NaCl, 2 mmol/L Na2EDTA; 1% NP40; 0.5% sodium deoxycholate; 0.1% SDS, 5 mmol/L sodium fluoride) containing protease inhibitors (0.1 mmol/L phenylmethylsulfonyl fluoride, 5 µg/mL aprotinin, 5 µg/mL pepstatin A and 1 µg/mL chymostatin). The lysate was spun at 13000 g for 20 min at 4 ℃. Protein concentration was determined using the Bradford assay. Proteins (20 µg) were separated on a 15% SDS PAGE and transferred onto a PVDF membrane. The membrane was first incubated with antibodies directed against LC3 (Sigma L8918; 1:2000) and then with secon dary antibodies (Santa Cruz, France) coupled with HRP (1:5000). Immunoreactive proteins were visualized on a Biorad Imager and bands size and density were measured using the Image Lab Software. The data were normalized against actin as an internal control.
Tbars production
C2C12 cells (10 6 cells) were harvested and homoge neized in a TrisHCl buffer (150 mmol/L, pH 7.1) and Tbars production determined as in [23] . The results were expressed as nmoles of MDA produced per mg of proteins. Protein amount was determined using the Bicinchoninic Acid Protein Assay (Pierce, France) with BSA as a standard.
Flow cytometric measurement of the superoxide production in the mitochondria with the MitoSox Red dye
MitoSoxRed labeling was carried out according as re commended by the manufacturer (Molecular Probes). Cells were harvested as above and resuspended in fresh medium. The reaction was carried out for 15 min at 37 ℃ in the dark with a final concentration of 5 µmol/L of MitoSox Red [24] . The cells were then centrifuged at 600 × g for 3 min and resuspended in DPBS. Analysis was performed using a Facscan cytometer (BD Bioscience), using 10000 cells and fluorescence was recorded with the FL3 channel.
Flow cytometric measurement of the mitochondrial transmembrane potential (Δψm) using the 3,3' -dihexyloxacarbocyanine iodide dye
After treatment, the cells were harvested, the culture medium was removed and kept in a 15 mL tube; the cells were washed with DPBS and trypsinized. The culture medium, washing DPBS and trypsinized cells were pooled and centrifuged at 600 g during 3 min. The cell pellet was resuspended in fresh medium. dihexyloxacarbocyanine iodide [DiOC6(3)] labeling was carried out according to Molecular Probes recommendations; briefly cells were incubated 20 min at 37 ℃ with 20 nmol/L of DiOC6 (3), cells were then centrifuged at 600 × g for 3 min then resuspended in DPBS. The analysis was performed using a Facscan cytometer, counting 10000 cells and recording fluorescence with the FL1 channel.
Cellular organization
Cells were grown on Labtek slides and treated as de scribed above. After treatment, cells were labeled with MitoSox Red [25] and Hoechst 33342 (final concentration of 10 µg/mL). After staining, cells were fixed with 4% formaldehyde in DPBS during 1 h. Cells were mounted in Dakocytomation fluorescence medium (Dako, Copenhagen, Denmark) and after solidification of the mounting medium, cells were observed with a LSM confocal microscope (Zeiss) in plane mode with an EC Plan-Neofluar objective (40 ×/1.30 Oil DIC M27).
Statistical analysis
Results are expressed as the mean ± SD. The statistical significance of differences between treatments was determined with KaleidaGraph (Synergy software) using the ANOVA test with Dunnett Post Hoc test.
RESULTS
Menadione alters mitochondrial membrane potential in C2C12 cells, L-carnitine restores mitochondrial membrane potential
The effect of menadione on mitochondrial integrity was estimated by monitoring potential variations using the potential sensitive fluorochrome DiOC6(3). In the absence of menadione, no effect of Lcarnitine was observed. In the presence of menadione, a significant decrease in the mitochondrial transmembrane potential was observed ( Figure 1 ). This decrease appeared to be dosedependent: While 77% of the cells were able to accumulate the fluorochrome in the absence of menadione, only 51%
Le Borgne F et al . L-carnitine limits superoxide production were concentrating the Dioc in the presence of 6 µmol/L of menadione and the percentage decreased to respectively 8% and 6% at concentrations of menadione of 9 and 12 µmol/L. Lcarnitine treatment appeared to prevent menadioneinduced loss of mitochondrial transmembrane potential. As shown on Figure 1 , the number of cells able to preserve their mitochondrial transmembrane potential was much higher among the Lcarnitine treated cells than among untreated cells. At 9 µmol/L of menadione and in the presence of Lcarnitine, 70% of the cells exhibited fluorescence. At 12 µmol/L of menadione and in the presence of carnitine, the percentage of mitochondrial integrity was much lower than in control cells, but was still higher than in menadioneonly treated cells.
Mitochondrial morphology is altered by menadione
To evaluate intracellular organization of the nucleus and the mitochondria, cells were stained with Hoechst 33342 and MitosoxRed. Cells mounted in fluorescence medium were observed with a LSM confocal microscope in plane mode ( Figure 2 ). Control cells exhibited well identified mitochondria, with a homogeneous repartition in the cytoplasm; the same organization was observed in cells treated with Lcarnitine. After treatment with 9 µmol/L of menadione during 24 h, the mitochondrial network appeared damaged with most of the mitochondria located around the nucleus. Such modifications were not observed on cells simultaneously treated with 500 µmol/L Lcarnitine and with 9 µmol/L menadione for 24 h. In these con ditions, mitochondria and cell structure were similar to those of control cells.
L-carnitine prevents menadione-induced free radical generation in the mitochondria
The global ROS production was evaluated by the measure of thiobarbituric reactive species. Tbars production in C2C12 cells was determined at intervals from 0 to 24 h after treatment with four different concentrations of menadione (0 µmol/L: Figure 3A ; 6 µmol/L: Figure 3B ; 9 µmol/L: Figure 3C and 12 µmol/L: Figure 3D ). In the absence of menadione, no effect on Tbars production was observed and Lcarnitine supplementation remained without effect. In the presence of 6 µmol/L of mena dione, Tbars production increased after 6 h of treatment, and was found to be maximal after 8 h of treatment. Lcarnitine supplementation fully inhibited this increase and no differences were found among Lcarnitine treated cells. With a treatment of 9 µmol/L of menadione, Tbars production was increased earlier than before and a sig nificant difference was observed after 2 h of treatment.
The effect of menadione was maximal after 4 h of treatment. Again, Lcarnitine addition fully abolished the effect of menadione and in the presence of Lcarnitine, no increase in Tbars production was observed. In the presence of 12 µmol/L of menadione, the increase in Tbars production was rapid and appeared to be maximal after 2 h of treatment. Lcarnitine supplementation was able to prevent this increase, even if one can observe a slight increase after 24 h of treatment ( Figure 3A) . The mitochondrial generation of ROS was evaluated by analyzing C2C12 cells stained with MitosoxRed by flow cytometry. Carnitine treatment did not alter the basal production of mitochondrial ROS. Menadione treatment was found to induce an increase in the production of ROS in the mitochondria in a dose dependent manner. At a concentration of 6 µmol/L of menadione, a significant increase in the number of cells producing ROS was observed ( Figure 3B ) and when the concentration of menadione reached 9 µmol/L, more than 90% of the cells produced ROS. Lcarnitine treatment was able to decrease the mitochondrial production of ROS for concentrations of menadione less than 12 µmol/L.
L-carnitine limits the autophagy process induced by menadione in C2C12 cells
Microtubuleassociated protein light chain 3 (LC3) is con sidered as one of the more accurate markers for auto phagy [26] . During the initiation of autophagy, a cytosolic form of LC3 (LC3Ⅰ) is conjugated to phosphatidylethanolamine leading to the formation of LC3Ⅱ [27] . Due to its hydro phobic property, the PE group increases the migration of the LC3 protein in a SDSPAGE gel. We examined the changes in endogenous LC3 after menadione and carnitine treatments in C2C12 cells.
Menadione significantly increased the level of LC3
Ⅱ proteins in a dosedependent manner (Figure 4 ).
Lcarnitine treatment did not modify autophagy in control cells (i.e., untreated with menadione). At the concen trations of 6 and 9 µmol/L of menadione, adding carnitine decreases the level of LC3Ⅱ significantly suggesting a protective effect of carnitine on autophagy. At the concentration of 12 µmol/L of menadione, Lcarnitine supplementation remained ineffective in reducing autophagy. At this concentration, the level of LC3Ⅱ was found to be the same between Lcarnitine treated and untreated cells. 
DISCUSSION
Due to the high rate of oxidative processes and the abundance of myoglobin, muscle cells are very suscep tible to ROS damage which are responsible of various types of damages that can lead to cell death or to cell ineffectiveness [28] . It has been shown that ROS are implicated in the normal aging process but also in pa thological processes. Muscle diseases like Duchenne muscular dystrophy make muscle cells more susceptible to ROS damages [29, 30] , leading to premature death or malfunction. Menadione (2methyl1, 4naphthoquinone, vitamin K3) is a quinonecontaining compound. Reductive enzymes such as microsomal NADPHcytochrome P450 reductase and mitochondrial NADHubiquinone oxidoreductase are able to metabolize menadione with the subsequent formation of unstable semiquinones. These molecules can enter into a redox cycle with molecular oxygen leading to the formation of quinone and the gene ration of reactive oxygen species, including H2O2, O2
• and, in the presence of metal ions, to OH• [31] . Menadione is widely used to study the oxidative stress on various types of cells [29, 31, 32] . In this study, we showed that menadione induced an oxidative stress in C2C12 cells leading to cell death. The lethal dose 50 was calculated and found to be 6 µmol/L. In addition, menadione induced a significant increase in ROS generation in the mitochondria; at a dose of 6 µmol/L of menadione, more than 67% of the cells were over producing ROS. Menadione was also able to induce autophagy in C2C12 cells. The oxidative stress is also associated with a rearrangement in mitochondrial distribution inside the muscle cell. This aspect is also encountered in several diseases associated with a loss of myofibrillar organization (e.g., cells lacking desmin [33] or plectin [34] ). It is very likely that the change in mito chondrial distribution impacts cell function.
The data presented in this paper are partly in agreement with those of Chiou et al [32] who described that menadione (used on C2C12 in a culture medium without FCS) was able to induce massive cell death. Privation of serum for C2C12 cells is known to initiate differentiation and deeply changes the phenotype of the cells [35] . In our experimental conditions, Lcarnitine was added before the induction of the oxidative stress by menadione and appeared to protect C2C12 cells against ROS damages. For any concentration of menadione, Lcarnitine treatment protected cells against menadione toxicity. This phenomenon is observed at all tested menadione concentrations and while the LD50 of untreated C2C12 was 6 µmol/L, in the presence of Lcarnitine, the LD50 was calculated at 11 µmol/L. In C2C12 cells, Lcarnitine supplementation was able to diminish cell death but also to reduce ROS production and to protect against mitochondrial transmembrane depolarization.
Currently, it is known that Lcarnitine is a cofactor in the channeling of fatty acids inside the cell. It is involved in fatty acid oxidation by playing a role of cofactor in the transport of acyl groups across the mitochondrial membrane [36] . Beside its role in fatty acid oxidation, Lcarnitine, added to the food, has been shown to coun teract some effects associated with aging on mito chondria and on muscle [3739] . Moreover, Lcarnitine has been shown to prevent oxidative stress, to regulate nitric oxide production and to control the activity of enzymes involved in the defense against oxidative damage [40] and mitochondrial dysfunction [41] . Among the enzymes whose activity is protected by Lcarnitine are found the catalase and the superoxide dismutase [42] , two of three major enzymes involved in ROS detoxification. In this study we were able to prove that Lcarnitine may act on the intracellular ROS status either by decreasing mitochondrial ROS production, either by increasing defense against these reactive molecules produced in mitochondria, or either by scavenging ROS at the mitochondrial level.
ACKNOWLEDGMENTS
The authors wish to thank the Association Française contre les Myopathies for financial support.
COMMENTS
Background
By controlling metabolism, L-carnitine seems to be able to limit reactive oxygen species (ROS) production under certain circumstances. In this paper, the protective effect of L-carnitine was assessed on muscle cells. L-carnitine appeared to limit ROS production in muscle cells and protecting them against oxidative stress.
Research frontiers
Muscle is a tissue with a high concentration of mitochondria and likely to produce high level of ROS. ROS may then induce oxidative stress and damage to muscle cells. Protecting muscle cells against oxidative stress was the authors' objective. 
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